TCR2 Therapeutics Inc. buy BiotechBee
Start price
04.02.23
/
50%
€1.31
Target price
04.02.24
€3.00
Performance (%)
34.48%
End price
05.05.23
€1.76
Summary
This prediction ended on 05.05.23 with a price of €1.76. With a performance of 34.48% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| TCR2 Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.654% | 1.989% | 14.984% |
| iShares Nasdaq 100 | 0.903% | 5.664% | 36.140% |
| iShares Nikkei 225® | -0.740% | -1.363% | 10.792% |
| iShares S&P 500 | -0.013% | 3.020% | 28.126% |
According to BiotechBee what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year